These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20231420)

  • 1. Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors.
    Ouertatani-Sakouhi H; Liu M; El-Turk F; Cuny GD; Glicksman MA; Lashuel HA
    J Biomol Screen; 2010 Apr; 15(4):347-58. PubMed ID: 20231420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
    Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
    J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
    El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
    Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
    Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
    Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays.
    Xu L; Zhang Y; Zheng L; Qiao C; Li Y; Li D; Zhen X; Hou T
    J Med Chem; 2014 May; 57(9):3737-45. PubMed ID: 24712915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A visible wavelength spectrophotometric assay suitable for high-throughput screening of 3-hydroxy-3-methylglutaryl-CoA synthase.
    Andrew Skaff D; Miziorko HM
    Anal Biochem; 2010 Jan; 396(1):96-102. PubMed ID: 19706283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Novel Inhibitors of the Tautomerase Activity of Macrophage Migration Inhibitory Factor (MIF).
    Zapatero MC; Pérez P; Vázquez MJ; Colmenarejo G; de Los Frailes M; Ramón F
    J Biomol Screen; 2016 Jun; 21(5):446-58. PubMed ID: 26933127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending matrix-assisted laser desorption/ionization triple quadrupole mass spectrometry enzyme screening assays to targets with small molecule substrates.
    Rathore R; Corr JJ; Lebre DT; Seibel WL; Greis KD
    Rapid Commun Mass Spectrom; 2009 Oct; 23(20):3293-300. PubMed ID: 19757451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
    Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
    Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
    McLean LR; Zhang Y; Li H; Li Z; Lukasczyk U; Choi YM; Han Z; Prisco J; Fordham J; Tsay JT; Reiling S; Vaz RJ; Li Y
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6717-20. PubMed ID: 19836948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
    He M; Metz C; Cheng KF; Ling J; Coleman T; VanPatten S; Al-Abed Y
    Arch Pharm (Weinheim); 2014 Feb; 347(2):104-7. PubMed ID: 24243226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
    Garai J; Molnár V; Eros D; Orfi L; Lóránd T
    Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
    Garai J; Lóránd T; Molnár V
    Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
    Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
    Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.
    Cvetkovic I; Stosic-Grujicic S
    Int Immunopharmacol; 2006 Oct; 6(10):1527-34. PubMed ID: 16919824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor.
    Stamps SL; Fitzgerald MC; Whitman CP
    Biochemistry; 1998 Jul; 37(28):10195-202. PubMed ID: 9665726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIF in autoimmunity and novel therapeutic approaches.
    Stosic-Grujicic S; Stojanovic I; Nicoletti F
    Autoimmun Rev; 2009 Jan; 8(3):244-9. PubMed ID: 18721909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A homogeneous time-resolved fluorescence-based high-throughput screening system for discovery of inhibitors of IKKbeta-NEMO interaction.
    Gotoh Y; Nagata H; Kase H; Shimonishi M; Ido M
    Anal Biochem; 2010 Oct; 405(1):19-27. PubMed ID: 20522330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
    Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
    Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.